November 22, 2022
As a leading CRO, we offer a wide array of histopathology services.
Our histopathology facilities have trained in-house pathologists and multiple platforms to partner with you and provide integrated solutions for your specific clinical trial needs.
Discover how CellCarta advances histopathology research and services.
We offer testing services for all phases of clinical trials including:
As a CAP/CLIA-certified lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU, and other global submissions.
Building on our comprehensive services, CellCarta’s Histology CRO capabilities extend to custom assay development and validation, supporting a wide range of clinical and research applications.
Our expert team provides histology support for CROs, offering tailored solutions to meet the specific requirements of each study. This includes detailed consultation on sample preparation, staining protocols, and data interpretation.
In addition to our core services, we provide advanced molecular pathology services, including in situ hybridization (ISH) and fluorescence in situ hybridization (FISH).
These techniques enable the detection of specific biomarkers and genetic materials within tissue samples, aiding in the identification and characterization of diseases. Our digital pathology platform, featuring whole slide imaging and automated image analysis, allows for accurate, reproducible data generation and efficient workflow management.
We collaborate with industry leaders to enhance our service offerings and stay at the forefront of histopathology innovations.
Our histopathology software solutions, such as advanced AI-driven platforms, streamline data analysis and improve clinical testing. This integration of cutting-edge technology ensures that our clients receive the most reliable and insightful data possible.
Our commitment to quality goes beyond our technical capabilities. As a CAP/CLIA certified lab, we adhere to stringent quality control measures and global standards.
This ensures that our data and analyses are robust, reproducible, and ready for regulatory submissions worldwide, including FDA and EU approvals.
Our comprehensive quality assurance program includes regular proficiency testing and adherence to best practices in laboratory operations.
CellCarta offers unparalleled expertise in histopathology CRO services, making us a trusted partner for pharmaceutical companies and research institutions. Our comprehensive range of services, from routine histology to advanced molecular analyses, combined with our commitment to quality and innovation, ensures that we deliver accurate, high-quality data tailored to your specific needs.
CellTalk Blog
September 4, 2024
Histopathology
More infoCellTalk Blog
August 30, 2024
Histopathology
More infoScientific Publications
August 5, 2024
Histopathology
More infoBrochures & Infographics
February 29, 2024
Histopathology
More info